St. Jude Medical Receives FDA And CE Mark Approvals for QuickOpt Timing Cycle Optimization Feature for Frontier II Pacemakers

July 2, 2007

St. Jude Medical Inc. revealed U.S. Food and Drug Administration and European CE Mark approvals for the QuickOpt Timing Cycle Optimization feature for its Frontier II cardiac resynchronization therapy pacemaker or CRT-P.
RTT News